Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer
Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link